510(k) Report

510(k) · Cleared

Cleared

Kelocote Scar Gel and Kelocote Laser Gel

K973572510(k) TraditionalCleared Oct 21, 199732-day reviewClass I21 CFR 878.4025

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hanson Medical, Inc. · MDA Elastomer, Silicone, For Scar Management

Cleared on Oct 21, 1997 after a 32-day review. The FDA summary names its predicate without a number. 1 later device descends from it.

Decided
Oct 21, 1997
Review
32 days
Class
Class I
Product code
MDA
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 1999: 1 descendant cleared1995200020052010201520202025
  1. This deviceK973572 Kelocote Scar Gel and Kelocote Laser GelHanson Medical, Inc. · 1997
  2. Descendant · cites it directly · 0 of its ownK991970 Scarease Sheets & Scarease GelPillar Surgical · 1999

Most influential descendants

Showing 1 of 1 · See all
  • K991970Scarease Sheets & Scarease GelPillar Surgical · 1999 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K973572Kelocote Scar Gel and Kelocote Laser GelHanson Medical, Inc.1997—
+1K991970Scarease Sheets & Scarease GelPillar Surgical1999—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
FIG. 1 — Lineage of K973572, 1997–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MDA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Kelocote Gel of Allied Biomedical
Named without a submission number
—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K991970Scarease Sheets & Scarease GelPillar Surgical19990

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K991970 (Pillar Surgical, 1999) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MDA devices

MDA Elastomer, Silicone, For Scar Management: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MDA

2in 2011

2009: 12011: 2
2007high 2 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MDA

Too few MDA 510(k)s in any year since 2007 to give a median.

Recalls per year · MDA

No recall names MDA since 2007.

Adverse event reports per year · MDA

3in 2025

2007: 32013: 22014: 12015: 22016: 52017: 32018: 22019: 52020: 42021: 32023: 82025: 3
2007high 8 (2023) · low 0 (2008)2025

MAUDE reports naming product code MDA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20080—00
20091—00
20100—00
20112—00
20120—00
20130—02
20140—01
20150—02
20160—05
20170—03
20180—02
20190—05
20200—04
20210—03
20220—00
20230—08
20240—00
20250—03
20260—0—

What is it indicated for?

KELOCOTE SCAR GEL:

FOR THE MANAGEMENT OF HYPERTROPHIC SCARS AND KELOID SCARS AND ASSOCIATED ERYTHEMA SECONDARY TO ANY TRAUMA CAUSING SCARS

KELOCOTE LASER GEL:

FOR THE MANAGEMENT OF HYPERTROPHIC SCARS AND KELOID SCARS AND ERYTHEMA SECONDARY TO LASER RESURFACING

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973572: Kelocote Scar Gel and Kelocote Laser Gel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K973572

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026